6915 — Jiangxi Institute of Biological Products Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.12bn
- HK$1.64bn
- CNY235.41m
Annual cashflow statement for Jiangxi Institute of Biological Products, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 63.6 | 91.8 | 109 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 2.49 | 16.3 | -12.3 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -9.22 | -16.4 | -52.4 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 68.6 | 104 | 56.8 |
| Capital Expenditures | -31.1 | -16.6 | -36 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 30 | 0.344 | 11 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -1.04 | -16.3 | -25 |
| Financing Cash Flow Items | -45.3 | -68.3 | -12.6 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -63.3 | -91.3 | -12.6 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 4.37 | -3.53 | 19.2 |